Integrative Practitioner

By Deborah Borfitz For decades now, doctors have been referring people suspected of having obstructive sleep apnea to a specialized medical facility for a polysomnogram (PSG). The gold-standard overnight test collects millions of data points from across the body, only a small subset of which gets prioritized for scoring the severity of the condition—notably, the apnea-hypopnea index (AHI) ranking how often their breathing slows or stops per hour of sleep.

By Deborah Borfitz Since the brain and body are inexorably connected and seem to modulate each other, it follows that the best way to help cancer patients suffering from depression is to view the condition holistically based on their systemic and brain biology and not just their lived experience, according to Gregory Jones, M.D., assistant professor of psychiatry at The University of Texas MD Anderson Cancer Center.

By Deborah Borfitz Scientists at the BuckInstitute for Research on Aging have used inductive reasoning to come up with a “Reproductive Resilience Hypothesis” suggesting that the ovary serves as the central biological hub helping to coordinate overall health.

By Integrative Practitioner Staff SoundHealth accelerates growth of its breathing and sleep disorder device portfolio; Wellinks expands commercial footprint for its predictive solution platform; DITTO expands menstrual health research platform; and more. $31.5M: Series A for Prostate Care Platform MaxQ Medical announced the closing of a $31.5 million Series A financing. Funds will be used to grow the team and advance the company’s clinical program.

By Deborah Borfitz The worried well the world over now have readily accessible and easy to self-administer home tests for assessing their risk for diabetes and chronic kidney disease, thanks to the computational skills of a pair of researchers at DTU Sustain, based at the Technical University of Denmark.

By Irene Yeh Originally developed to treat type 2 diabetes and later for obesity management, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are rapidly expanding into other areas of treatment. Researchers are asking whether these medications could play a role in treating eating disorders—a question that brings forth optimism and caution. Two studies illustrate the potential of treatment and GLP-1 RA abuse.

By Irene Yeh As incretin-based medications, including glucagon-like peptide-1 receptor agonists (GLP-1RAs) or glucose-dependent insulinotropic polypeptide (GIP) drugs, become increasingly common in obesity and weight management, questions remain about their use throughout a woman’s reproductive years.

By Deborah Borfitz Medical conditions vary widely in presentation, progression, and treatment response, with Down syndrome standing out as one of the most variable of all. The genetic occurrence, caused by an extra copy of chromosome 21, is widely considered one of the most heterogenous conditions, with highly variable clinical presentation from person to person.

By Irene Yeh Eating a healthy diet during pregnancy may come with an unexpected tradeoff: some foods recommended for good nutrition can also be sources of environmental chemical exposure. The United States Dietary Guidelines for Americans (DGA) recommend that pregnant people eat more fruits, vegetables, whole grains, dairy, and protein while limiting added sugars, sodium, saturated fats, and refined grains.

By Irene Yeh Originally developed to treat type 2 diabetes and later for obesity management, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are rapidly expanding into other areas of treatment. Researchers are asking whether these medications could play a role in treating eating disorders—a question that brings forth optimism and caution. Two studies illustrate the potential of treatment and GLP-1 RA abuse.